Literature DB >> 6991416

Growth characteristics of group A streptococci in a new chemically defined medium.

I van de Rijn, R E Kessler.   

Abstract

A new chemically defined medium for the growth of group A streptococci has been formulated. The advantages of this new medium over previously described defined media are: (i) rates of growth (i.e., doubling times) of 20 strains were comparable to the rates of growth in complex media; (ii) each strain grew to a higher culture density in the new defined medium than in complex media; (iii) transfer from complex media with small inocula was possible without any prior adaptation regimen; and (iv) the production of virulence factors (i.e., M protein and hyaluronic acid) and extracellular enzymes during growth in this new medium was comparable to that in complex media.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991416      PMCID: PMC550785          DOI: 10.1128/iai.27.2.444-448.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Group A hemolytic streptococci. I. A chemically defined medium for growth from small inocula.

Authors:  I GINSBURG; N GROSSOWICZ
Journal:  Proc Soc Exp Biol Med       Date:  1957-10

2.  Extracellular antigens in steady-state cultures of the hemolytic Streptococcus: production of proteinase at low pH.

Authors:  C A OGBURN; T N HARRIS; S HARRIS
Journal:  J Bacteriol       Date:  1958-08       Impact factor: 3.490

3.  Factors Necessary for Massive Growth of Group A Hemolytic Streptococcus.

Authors:  A W Bernheimer; A M Pappenheimer
Journal:  J Bacteriol       Date:  1942-04       Impact factor: 3.490

4.  Glutamine and the growth of Streptococcus haemolyticus.

Authors:  H McIlwain; P Fildes; G P Gladstone; B C Knight
Journal:  Biochem J       Date:  1939-02       Impact factor: 3.857

5.  The amino acid nutrition of group A hemolytic Streptococci, with reference to the effect of glutathione on the cystine requirement.

Authors:  H D SLADE; G A KNOX; W C SLAMP
Journal:  J Bacteriol       Date:  1951-11       Impact factor: 3.490

6.  Absence of type specific M antigen from group A streptococci grown in a chemically defined medium.

Authors:  M N Mickelson; H D Slade
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

7.  Growth of several cariogenic strains of oral streptococci in a chemically defined medium.

Authors:  B Terleckyj; N P Willett; G D Shockman
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

8.  Synthesis of M protein by group A hemolytic streptococci in completely synthetic media during steady-state growth.

Authors:  H C Davies; F Karush; J H Rudd
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

9.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever.

Authors:  G Husby; I van de Rijn; J B Zabriskie; Z H Abdin; R C Williams
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  212 in total

1.  Involvement of Lsp, a member of the LraI-lipoprotein family in Streptococcus pyogenes, in eukaryotic cell adhesion and internalization.

Authors:  Andrea Elsner; Bernd Kreikemeyer; Andrea Braun-Kiewnick; Barbara Spellerberg; Bettina A Buttaro; Andreas Podbielski
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

2.  Immunochemical studies and complete amino acid sequence of the streptokinase from Streptococcus pyogenes (group A) M type 12 strain A374.

Authors:  H Ohkuni; Y Todome; H Suzuki; M Mizuse; N Kotani; K Horiuchi; N Shikama; A Tsugita; K H Johnston
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Moonlighting glutamate formiminotransferases can functionally replace 5-formyltetrahydrofolate cycloligase.

Authors:  Linda Jeanguenin; Aurora Lara-Núñez; Anne Pribat; Melissa Hamner Mageroy; Jesse F Gregory; Kelly C Rice; Valérie de Crécy-Lagard; Andrew D Hanson
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

Review 4.  The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Authors:  Alexander V Dmitriev; Michael S Chaussee
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

5.  Lysogeny of Streptococcus pneumoniae with MM1 phage: improved adherence and other phenotypic changes.

Authors:  Jutta M Loeffler; Vincent A Fischetti
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

6.  Immunochemical analysis of streptococcal group A, B, and C carbohydrates, with emphasis on group A.

Authors:  J C Fung; K Wicher; M McCarty
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Binding of Streptococcus mutans antigens to heart and kidney basement membranes.

Authors:  M W Stinson; P K Barua; E J Bergey; R J Nisengard; M E Neiders; B Albini
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

8.  A Quorum Sensing-Regulated Protein Binds Cell Wall Components and Enhances Lysozyme Resistance in Streptococcus pyogenes.

Authors:  Artemis Gogos; Juan Cristobal Jimenez; Jennifer C Chang; Reid V Wilkening; Michael J Federle
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

9.  Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones.

Authors:  Xiao-Su Pan; Penelope J Hamlyn; Raquel Talens-Visconti; Fabiana L Alovero; Ruben H Manzo; L Mark Fisher
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide.

Authors:  Jason W Johnston; Lisa E Myers; Martina M Ochs; William H Benjamin; David E Briles; Susan K Hollingshead
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.